Merck Settles Patent Infringement Case for Zetia (ezetimibe)
12-May-2010 -
Merck & Co., Inc. and Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals, Ltd. have reached an agreement to settle their patent litigation involving Glenmark's challenge to Merck's patent covering ZETIA® (ezetimibe). Specifically, Glenmark challenged Merck's basic compound patent, RE ...
Merck
patent infringement
patent litigations